Should You Buy Applied DNA Sciences Inc (APDN) in Diagnostics & Research Industry?

A rating of 89 puts Applied DNA Sciences Inc (APDN) near the top of the Diagnostics & Research industry according to InvestorsObserver. Applied DNA Sciences Inc's score of 89 means it scores higher than 89% of stocks in the industry. Applied DNA Sciences Inc also received an overall rating of 61, putting it above 61% of all stocks. Diagnostics & Research is ranked 117 out of the 148 industries.

APDN has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on APDN!

See Full APDN Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Applied DNA Sciences Inc Stock Today?

Applied DNA Sciences Inc (APDN) stock has gained 0.94% while the S&P 500 has fallen -0.29% as of 1:35 PM on Thursday, Oct 5. APDN is up $0.01 from the previous closing price of $1.07 on volume of 5,225 shares. Over the past year the S&P 500 has gained 12.38% while APDN has fallen -25.52%. APDN lost -$0.55 per share the over the last 12 months. Click Here to get the full Stock Report for Applied DNA Sciences Inc stock.